Showcasing the latest in kidney care, research, and innovation. Follow for updates from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.
ASN Kidney Health Guidance is produced to encourage high-quality, patient-centered care across the spectrum of kidney health, from screening and early detection through palliative care. Check out the full collection: bit.ly/JASNKHG
SGLT2 inhibitors are now embedded in clinical practice guidelines to slow the progression of CKD in patients with and without diabetes mellitus. This Review discusses the kidney-protective effects of SGLT2 inhibitors bit.ly/CJN09380822wk
Combination diuretic therapy is a widely applied strategy to counter renal sodium avidity. This Review discusses the results of the key studies on combination diuretic therapy in the setting of acute heart failure and their findings bit.ly/CJASN0188@AmirKazory
AKI is a syndrome that is often multifactorial, especially in the hospitalized patient. This Review discusses the pathophysiology of three etiologies that cause AKI: kidney hypoperfusion, abdominal compartment syndrome, & urinary tract obstruction bit.ly/CJN15341121
The benefits of SGLT2 inhibitors in patients with CKD have been well established in major clinical trials. This Perspective examines if SGLT2 inhibitors are effective & safe in patients with severe CKD, dialysis, or kidney transplantation bit.ly/CJASN0221@StefanPBerger
Lupus nephritis is seeing more enriching immunotherapies, but important unmet needs remain. In this #ASNCJASN article: authors detail how to focus on histological signs of immunological activity triggering immunotherapy vs signs of kidney injury requiring care for CKD.
SGLT2 inhibitors are a critical part of clinical practice guidelines for the management of patients with cardiovascular disease with and without diabetes. This Review discusses the mechanisms by which they act and the potential changes in kidney function bit.ly/CJN09380822
SGLT2 inhibitors have become an integral part of clinical practice guidelines to slow CKD progression. This Review examines the mechanisms by which this class of compounds provide kidney protection and how they impact various aspects of kidney homeostasis bit.ly/CJN09380822
The cardiorenal syndrome refers to a group of complex, bidirectional pathophysiological pathways involving dysfunction in both the heart and kidney. This Review focuses on the cardiorenal syndrome encountered in the hospital setting bit.ly/CJASN064
The KDIGO 2021 Clinical Practice Guideline for the Management of BP in CKD includes new recommendations on BP management for individuals with non-dialysis CKD. This Kidney Case Conference: How I Treat article presents a case that incorporates these updates bit.ly/CJN13040921
Pseudohyperaldosteronism is a syndrome featuring hypokalemia, metabolic alkalosis and suppressed renin in the absence of elevated aldosterone levels. This Kidney Case Conference: How I Treat article presents a schema for diagnosis and management bit.ly/CJN14201021
Fluid overload is the primary reason for admission of patients with acute heart failure. In this Review, Dr @AmirKazory provides an overview of the results of the key studies on combination diuretic therapy in the setting of acute heart failure bit.ly/CJASN0188
The clinical benefits of SGLT2 inhibitors in patients with CKD have been well established. This Perspective explores if SGLT2 inhibitors will also be effective in patients with severe CKD, Dialysis, or Kidney Transplantation bit.ly/CJASN0221@StefanPBerger
Rhabdomyolysis is a condition characterized by the destruction of skeletal muscle fibers and the release of intracellular contents into the bloodstream. This article discusses the management of rhabdomyolysis-induced AKI bit.ly/CJASN0372@javo_neyra